While our data imply a dominant role for ID1 over ID2 and ID3, purely based on the 5–10‐fold higher expression of ID1 in primary, liver, and lung cancer samples, a modest increase in ID2 and ID3 was also observed between the primary tumour and lung metastases. The gene discussed is ID2; the disease is lung carcinoma.